JP2020536085A5 - - Google Patents

Download PDF

Info

Publication number
JP2020536085A5
JP2020536085A5 JP2020518682A JP2020518682A JP2020536085A5 JP 2020536085 A5 JP2020536085 A5 JP 2020536085A5 JP 2020518682 A JP2020518682 A JP 2020518682A JP 2020518682 A JP2020518682 A JP 2020518682A JP 2020536085 A5 JP2020536085 A5 JP 2020536085A5
Authority
JP
Japan
Prior art keywords
treatment
combination according
tuberculosis
medicament
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020518682A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020536085A (ja
JP7233059B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2018/077222 external-priority patent/WO2019068910A1/en
Publication of JP2020536085A publication Critical patent/JP2020536085A/ja
Publication of JP2020536085A5 publication Critical patent/JP2020536085A5/ja
Application granted granted Critical
Publication of JP7233059B2 publication Critical patent/JP7233059B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020518682A 2017-10-05 2018-10-05 結核に対する薬剤と組み合わせた環融合型チアゾリノ２－ピリドン Active JP7233059B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762568430P 2017-10-05 2017-10-05
US62/568,430 2017-10-05
US201862716054P 2018-08-08 2018-08-08
US62/716,054 2018-08-08
PCT/EP2018/077222 WO2019068910A1 (en) 2017-10-05 2018-10-05 THIAZOLINO 2-PYRIDONES WITH A FUSED CYCLE IN COMBINATION WITH A MEDICINE AGAINST TUBERCULOSIS

Publications (3)

Publication Number Publication Date
JP2020536085A JP2020536085A (ja) 2020-12-10
JP2020536085A5 true JP2020536085A5 (enExample) 2021-11-11
JP7233059B2 JP7233059B2 (ja) 2023-03-06

Family

ID=63840820

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020518682A Active JP7233059B2 (ja) 2017-10-05 2018-10-05 結核に対する薬剤と組み合わせた環融合型チアゾリノ２－ピリドン

Country Status (7)

Country Link
US (1) US11129816B2 (enExample)
EP (1) EP3691619A1 (enExample)
JP (1) JP7233059B2 (enExample)
KR (1) KR20200066315A (enExample)
CN (1) CN111246848A (enExample)
PH (1) PH12020550567A1 (enExample)
WO (1) WO2019068910A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018229141A1 (en) * 2017-06-13 2018-12-20 Quretech Bio Ab Ring-fused thiazolino 2-pyridones, methods for preparation thereof and their use in the treatment and/or prevention of a disease involving gram-positive bacteria
EP4003521B1 (en) * 2019-07-30 2024-05-29 Qurient Co. Ltd. Different forms of 6-chloro-2-ethyl-n-(4-(4-(4-(trifluoromethoxy)phenyl)piperidine-1-yl)benzyl)imidazo[1,2-a]pyridine-3-carboxamide
CN115551869B (zh) * 2020-05-08 2024-01-02 快尔生物技术公司 稠环2-吡啶酮化合物、其制备方法及其在治疗和/或预防涉及革兰氏阳性菌的疾病中的用途
CN112921107A (zh) * 2020-12-31 2021-06-08 深圳市慢性病防治中心(深圳市皮肤病防治研究所、深圳市肺部疾病防治研究所) 结核分枝杆菌异质性耐药检测方法、试剂盒及应用
CN113045494B (zh) * 2021-03-29 2022-04-26 四川大学华西医院 吡啶酮衍生物及其在制备预防和/或治疗结核分枝杆菌所引起的结核病的药物中的用途
CN115531388B (zh) * 2022-11-04 2024-03-22 首都医科大学附属北京胸科医院 治疗结核病的药物组合物
CN118593520B (zh) * 2024-05-23 2025-01-24 蚌埠医科大学 化合物k67在制备抗结核药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011229423B2 (en) 2010-03-18 2015-12-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Anti-infective compounds
US9029389B2 (en) 2011-04-21 2015-05-12 Institut Pasteur Korea Anti-inflammation compounds
WO2014185833A1 (en) 2013-05-13 2014-11-20 Telefonaktiebolaget L M Ericsson (Publ) Node in a telecommunications network, a virtual network element and methods for retrieving resource identification information
WO2014185853A1 (en) 2013-05-14 2014-11-20 Quretech Bio Ab Compounds and methods for treatment of chlamydia infections
PE20160238A1 (es) * 2013-07-26 2016-05-05 Sanofi Sa Composicion antituberculosa que comprende rifampicina, isoniazid, etambutol y pirazinamida y su proceso de preparacion
DK3027615T3 (da) * 2013-08-02 2021-10-25 Pasteur Institut Korea Antiinfektionsforbindelser
WO2016075296A1 (en) 2014-11-13 2016-05-19 Quretech Bio Ab 2,3-dihydro-thiazolo[3,2-a]pyridin-5-one derivatives, intermediates thereof, and their use as antibacerial agents
WO2017175182A1 (en) * 2016-04-08 2017-10-12 Quretech Bio Ab Ring-fused thiazolino 2-pyridones, methods for preparation thereof and their use in the treatment and/or prevention of tuberculosis

Similar Documents

Publication Publication Date Title
JP2020536085A5 (enExample)
EP4596041A3 (en) Farnesoid x receptor agonists and uses thereof
CA2956871C (en) Compounds active towards bromodomains
JP2015057451A5 (enExample)
WO2015165413A8 (zh) 一种新型的稳定型抗体药物耦联物及其制备方法和用途
JP2016515522A5 (enExample)
IL314347A (en) Combined treatment of lasmiditan and a CGRP antagonist for use in the treatment of migraine
EP4335418A3 (en) Compositions and methods for treating pterygium
WO2018004283A3 (ko) 글루카곤 유도체, 이의 결합체, 및 이를 포함하는 조성물, 및 이의 치료적 용도
WO2015077503A8 (en) Autotaxin inhibitor compounds
JP2017537928A5 (enExample)
JP2016147915A5 (enExample)
WO2016149501A3 (en) Modified therapeutic agents and compositions thereof
WO2015066302A3 (en) Compositions, methods of use, and methods of treatment
JP2018202656A5 (enExample)
EP4324824A3 (en) Combination antibacterial composition and short-course antibacterial regimen
CN110035744A (zh) 一种尼拉帕尼缓控释药物组合物及其用途
IL276952A (en) History of 4,2-diaminoquinazolines and their medicinal uses
EP3318282A4 (en) AGGREGATE COMPOSITION CARRIER AND COMPOSITION THEREOF
CY1123844T1 (el) Φαρμακευτικες συνθεσεις και χρησεις που απευθυνονται σε διαταραχες λυσοσωμιακης αποθηκευσης
WO2016191458A3 (en) Pharmaceutical compositions affecting mitochondrial redox state and methods of treatment
CA3010981A1 (en) Therapeutic nanoparticles for the treatment of neuroblastoma and other cancers
HUE057216T2 (hu) Genotípus-rétegzés cukorbetegség kezelésében és megelõzésében
JP2017197541A5 (enExample)
EA201991287A1 (ru) Твердые фармацевтические композиции на основе тикагрелора для перорального применения